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Background and aims: There is increasing evidence linking arterial (mainly aortic) stiffness and type 2
diabetes, a risk factor for arterial stiffness, to cognitive impairment and dementia. However, data on
carotid stiffness, which may be especially relevant for cognitive performance, are scarce, and few studies
have addressed the interplay between arterial stiffness, type 2 diabetes, and cognitive performance.
Methods: We studied individuals with (n ¼ 197) and without (n ¼ 528) type 2 diabetes, who completed a
neuropsychological test battery and underwent applanation tonometry and vascular ultrasound to
evaluate aortic (i.e. carotid-to-femoral pulse wave velocity) and carotid stiffness (i.e. distensibility,
compliance and Young's elastic modulus). Linear regression analyses were performed and adjusted for
demographics, vascular risk factors, and depression.
Results: Overall, our results showed that carotid, but not aortic, stiffness was associated with worse
cognitive performance, primarily in the domains of processing speed (standardized regression coefﬁcient
for distensibility 0.083, p ¼ 0.040; compliance 0.077, p ¼ 0.032) and executive function and attention
(distensibility 0.133, p ¼ 0.001; compliance 0.090, p ¼ 0.015; Young's elastic modulus 0.081,
p ¼ 0.027). These associations did not differ by diabetes status. The differences in cognitive performance
between individuals with and without type 2 diabetes (mean difference in domain scores relative to
those without diabetes for free recall memory 0.23, processing speed 0.19, executive function and
attention 0.23; all p  0.009 and adjusted for demographics, traditional vascular risk factors, and
depression) were not substantially altered after additional adjustment for carotid stiffness.
Conclusions: Our ﬁndings suggest that carotid stiffness is associated with cognitive performance in both
individuals with and without diabetes, but does not mediate the relationship between type 2 diabetes
and cognitive dysfunction.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).dicine, Maastricht University Medical Centre þ, P. Debyelaan 25, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
tehouwer).
r Ireland Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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In the ageing population, a rapidly increasing number of in-
dividuals will face cognitive deterioration later in life. It is esti-
mated that in the United States, 36% of individuals aged over 70 are
affected by some form of cognitive impairment [1]. Yet, the path-
ophysiological mechanisms underlying age-related cognitive
decline remain incompletely understood. Vascular factors are likely
to be involved [2] and may not be limited to local abnormalities of
the cerebral vasculature, but may also include systemic vascular
alterations such as arterial stiffening.
Arterial stiffening is part of the normal ageing process and re-
sults from a complex interplay between structural and cellular
changes within the arterial wall [3]. These changes include
degenerative alterations, such as collagen accumulation, elastin
fragmentation, and endothelial dysfunction [3]. In theory, stiffening
of (central) elastic arteries will hamper the natural cushioning
function of the arterial system, thereby increasing pulsatility of
pressure and ﬂow in the brain vasculature. This increased pulsatile
load can cause microvascular damage [4,5] and may ultimately
affect brain function.
Over the last decade, studies have collectively provided some
evidence that arterial stiffness is negatively, but weakly, associated
with cognitive performance [6]. So far, the main focus has been on
carotid-to-femoral pulsewave velocity (cfPWV), ameasure of aortic
stiffness that is considered the gold standard for the assessment of
arterial stiffness [7]. cfPWV, however, reﬂects stiffness of an arterial
segment with mixed elastic and muscular properties [7], while
stiffening of elastic and muscular arteries may differentially affect
brain function, as the cushioning function of arteries diminishes
from the most elastic to the more muscular ones [7]. To date,
studies evaluating the association of local stiffness of the pre-
dominantly elastic common carotid artery with cognitive perfor-
mance are scarce and have yielded conﬂicting results [8,9].
Moreover, few studies have explored the interplay between arterial
stiffness, cognitive performance, and type 2 diabetes. Type 2 dia-
betes is known to be associatedwith a variety of cognitive problems
[10], ranging from subtle cognitive decrements to overt dementia,
and a growing body of evidence also suggests [11,12] that diabetes
accelerates arterial stiffening. In addition, the ability of cerebral
arteries to withstand increased pressure pulsatility may be
decreased in individuals with diabetes [5]. As such, it can be hy-
pothesized that arterial stiffness is involved in diabetes-associated
cognitive problems, a hypothesis that is corroborated by data
linking arterial stiffness to other microvascular complications of
type 2 diabetes (e.g. nephropathy [13] and retinopathy [14]).
In view of the above, the aim of the present study was twofold.
First, we investigated whether arterial stiffness was associated with
cognitive performance in individuals with and without type 2
diabetes, and whether any such associations differed between
aortic and carotid stiffness. Second, we investigated whether
diabetes-associated impairment of cognitive performance could be
explained by diabetes-associated increases in arterial stiffness,
either aortic or carotid.
2. Materials and methods
2.1. Study population
In this study, we used data from The Maastricht Study, an
ongoing observational prospective population-based cohort study
that includes individuals aged 40e75 years living in the southern
part of the Netherlands. The rationale and design have been
described previously [15] and are summarised in the Online Sup-
plement. For the present study, cross-sectional data from the ﬁrst866 participants were used who completed the baseline survey
between November 2010 and March 2012. Participants with type 1
diabetes (n¼ 4) or possible dementia (i.e. those with a Mini Mental
State Examination score <24, n ¼ 3) were not eligible for the pre-
sent study. From the eligible cohort, we additionally excluded a
total of 134 (16%) individuals because of missing data on one or
more of the following variables: cognitive performance (n ¼ 20),
cfPWV (n ¼ 41; due to insufﬁcient quality (n ¼ 13) or logistical
reasons (n¼ 28)), measures of local carotid stiffness (n¼ 62; due to
technical failure (n ¼ 5) or logistical reasons (n ¼ 57)), or one or
more covariates (n ¼ 91). Therefore, 725 individuals were available
for analysis of aortic stiffness, cognitive performance, and type 2
diabetes and 711 for analysis of indices of carotid stiffness, cognitive
performance, and type 2 diabetes. Characteristics of individuals
with complete and incomplete data are shown in Table S1 (Online
Supplement).
The Maastricht Study has been approved by the institutional
medical ethical committee (NL31329.068.10) and the Netherlands
Health Council under the Dutch “Law for Population Studies”
(Permit 131088-105234-PG). All participants gavewritten informed
consent.
2.2. Cognitive assessment
A concise battery (30 min) of neuropsychological tests was
administered to assess cognitive performance [15]. For conceptual
clarity, and to reduce the number of cognitive outcomes, test results
were divided into three cognitive domains (i.e. free recall memory,
processing speed, and executive function and attention), as speci-
ﬁed in the Online Supplement. In short, free recall memory was
evaluated using the Verbal Learning Test by averaging total im-
mediate and delayed recall scores. The composite score for infor-
mation processing speed was derived from the Stroop Colour Word
Test Part I and II, the Concept Shifting Test Part A and B, and the
Letter-Digit Substitution Test. Executive function and attention was
assessed by the Stroop Colour Word Test Part III and the Concept
Shifting Test Part C. Where necessary, individual test scores were
inverted so that higher scores indicated better cognitive
performance.
2.3. Diabetes status
A two-hour seven-sample oral glucose tolerance test was used
to assess participants' glucose metabolism status, as previously
described in more detail [15]. Based on the WHO 2006 diagnostic
criteria [16], individuals were classiﬁed as having normal glucose
metabolism, impaired glucose metabolism, or diabetes. Partici-
pants were also considered to have type 2 diabetes if they used
glucose-lowering medication without a prior diagnosis of type 1
diabetes.
2.4. Measures of arterial stiffness
Details on the measures of arterial stiffness and their repro-
ducibility are provided in the Online Supplement. During the
vascular assessment, brachial systolic, diastolic, and mean arterial
pressure (MAP) were determined repeatedly with a 5-min interval,
using an oscillometric device (Accutorr Plus, Datascope Inc., Mon-
tvale, NJ, USA), and the average of these measurements was
calculated.
2.5. Carotid-to-femoral pulse wave velocity
Carotid-to-femoral pulse wave velocity (cfPWV) was deter-
mined according to recent guidelines [17] with the use of
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Australia), as speciﬁed in the Online Supplement.
2.6. Indices of carotid stiffness
Elastic properties of the left common carotid artery (at least
10 mm proximal to the carotid bulb) were obtained by using an
ultrasound scanner equipped with a 7.5-MHz linear probe (MyLab
70, Esaote Europe B.V., Maastricht, the Netherlands). This setup
enabled the measurement of diameter (D), distension (DD) and
intima-media thickness (IMT) as described elsewhere [18,19] and
summarised in the Online Supplement. Combined with brachial
pulse pressure (PP), these measures were used to calculate the
following indices [20]:
 Carotid artery e Distensibility Coefﬁcient (CarDC)
DC ¼ (2DD$D þ DD2)/(PP$D2) (103 kPa1)
 Carotid artery e Compliance Coefﬁcient (CarCC)
CC ¼ p$(2D$DD þ DD2)/4PP (mm2 kPa1)
 Carotid artery e Young's elastic modulus (CarYEM)
YEM ¼ D/(IMT$DC) (103 kPa)
CarDC represents arterial stiffness, CarYEM the stiffness of the
arterial wall material at operating pressure, and CarCC arterial
buffering capacity. Please note that higher values of cfPWV and
CarYEM, but lower values of CarDC and CarCC reﬂect greater arte-
rial stiffness.
2.7. Covariates
A detailed description of the covariates is provided in the Online
Supplement.
2.8. Statistical analyses
All analyses were performed using SPSS version 21.0 for Win-
dows (IBM SPSS, IBM Corp, Armonk, NY, USA). Variables with a
skewed distribution were transformed with the natural logarithm.
A two-sided p-value <0.05 was considered statistically signiﬁcant.
No adjustments were made for multiple comparisons [21].
Multiple linear regression analyses were used to explore the
association between measures of arterial stiffness, cognitive per-
formance, and type 2 diabetes. The associations were adjusted for
potential confounders, including demographic characteristics (i.e.
age, sex, and educational level), haemodynamic factors (i.e. MAP
and heart rate obtained during vascular assessment), cardiovascu-
lar risk factors (i.e. use of antihypertensive or lipid-modifying
medication, total/high density lipoprotein-cholesterol ratio, tri-
glyceride concentration, body mass index, smoking, alcohol con-
sumption, and prior cardiovascular disease), and current
depression where appropriate, as indicated in the tables. We
deliberately chose to use slightly different models of adjustment
across the different associations. Speciﬁcally, analyses with mea-
sures of arterial stiffness (e.g. the association between arterial
stiffness and cognitive performance) were adjusted for mean
arterial pressure to disentangle blood pressure-dependent andeindependent effects of arterial stiffness on cognitive performance.
For this purpose, mean arterial pressure was chosen as it provides
information on the non-pulsatile component of blood pressure. The
association between type 2 diabetes and cognitive performance, on
the other hand, was adjusted for (ofﬁce-based) systolic and dia-
stolic blood pressure to enhance the comparability of ﬁndings with
other studies. Multiplicative terms (e.g. CarDC * type 2 diabetes)
were incorporated in the regression model to test interaction ef-
fects between type 2 diabetes and arterial stiffness on cognition
with a conﬁdence level of 90%. The assumptions of linear regression
were veriﬁed prior to all analyses.
The mediation effects of arterial stiffness on diabetes-associated
impairment of cognitive performance were assessed by calculating
the changes in regression coefﬁcients of type 2 diabetes after in-
clusion of arterial stiffness indices in themodel. Corresponding 95%
conﬁdence intervals (CI) were estimated using SPSS macros pro-
vided by Preacher and Hayes [22] based on 5000 bootstrap itera-
tions. A signiﬁcant mediation effect was assumed when the 95% CI
excluded zero. Mediation analyses were restricted to cognitive
domains statistically signiﬁcantly affected by the presence of dia-
betes and indices of arterial stiffness associated with cognitive
performance.
Several sensitivity analyses were performed. First, analyseswere
repeated using indices of carotid stiffness that were calibrated with
local carotid instead of brachial pulse pressure. Second, to examine
the association between indices of carotid stiffness and cognitive
performance in greater detail, we investigated whether the indi-
vidual components of these indices (i.e. carotid diameter, disten-
sion, and pulse pressure) were associated with cognitive
performance. We also evaluated the correlation between indices of
carotid stiffness and carotid-to-femoral pulse wave velocity with
use of the Pearson correlation coefﬁcient. Third, we tested for the
presence of an association between, on the one hand, central pulse
pressure and the augmentation index, and, on the other, cognitive
performance. Although central pulse pressure and the augmenta-
tion index, which were both determined by radial applanation
tonometry (SphygmoCor, Atcor Medical, Sydney, Australia) and
pulse wave analysis, are considered indirect measures of arterial
stiffness, they may provide additional information on wave re-
ﬂections [7]. Fourth, we evaluated the effect of adjustment for 24-h
mean arterial pressure and heart rate instead of adjustment for the
average mean arterial pressure and heart rate obtained during
vascular assessment (24-h blood pressure data were only available
in a subpopulation). Similarly, analysis of the association between
type 2 diabetes and cognitive functioning were alternatively
adjusted for mean arterial pressure, or for 24-h systolic and dia-
stolic blood pressure [15], instead of ofﬁce blood pressure. Fifth, we
explored whether the association between type 2 diabetes and
cognitive performance, or between type 2 diabetes and arterial
stiffness, differed by hypertension status [15]. Lastly, the potential
confounding effects of physical activity (self-reported hours of
moderate to vigorous physical activity per week) were explored.
3. Results
Table 1 shows the characteristics of the study population
(n ¼ 725; mean age 60 ± 8 years) with (n ¼ 197) and without
(n ¼ 528) diabetes. Overall, individuals with type 2 diabetes were
older, more often male, and had a more adverse cardiovascular risk
proﬁle. They were also more likely to have a history of cardiovas-
cular disease, except for stroke, and were, in general, less educated
than individuals without diabetes. The prevalence of depression
did not differ between the two groups.
Of the 528 individuals without diabetes, 124 (23%) were classi-
ﬁed as having impaired glucose metabolism. Age- and sex-adjusted
Table 1
Characteristics of individuals with and without type 2 diabetes.
Clinical characteristics Total (n ¼ 725) Type 2 diabetes (n ¼ 197) No type 2 diabetes (n ¼ 528) p-valuea
Age (years) 60 ± 8 63 ± 7 58 ± 8 <0.001
Male 396 (54.6%) 137 (69.5%) 259 (49.1%) <0.001
Educational level
(low/middle/high)
113/302/310
(15.6%/41.7%/42.8%)
50/98/49
(25.4%/49.7%/24.9%)
63/204/261
(11.9%/38.6%/49.4%)
<0.001
BMI (kg/m2) 27.2 ± 4.4 29.6 ± 4.7 26.3 ± 4.0 <0.001
Total cholesterol (mmol/L) 5.2 ± 1.2 4.4 ± 1.0 5.5 ± 1.1 <0.001
HDL-cholesterol (mmol/L) 1.3 ± 0.4 1.1 ± 0.3 1.4 ± 0.4 <0.001
Total/HDL cholesterol ratio 4.2 ± 1.2 4.2 ± 1.1 4.2 ± 1.3 0.678
Triglycerides (mmol/L) 1.2 [0.9e1.8] 1.6 [1.1e2.3] 1.1 [0.8e1.6] <0.001
Lipid-modifying medication 255 (35.2%) 150 (76.1%) 105 (19.9%) <0.001
Brachial SBP (mmHg)b 128 ± 14 132 ± 13 127 ± 14 <0.001
Brachial DBP (mmHg)b 76 ± 7 76 ± 7 77 ± 8 0.385
Brachial MAP (mmHg)b 97 ± 10 99 ± 9 97 ± 10 0.025
Brachial PP (mmHg)b 52 ± 10 56 ± 11 50 ± 10 <0.001
Heart rate (bpm)b 63 ± 9 66 ± 10 62 ± 8 <0.001
Hypertensionc 413 (57.0%) 171 (86.8%) 242 (45.8%) <0.001
Antihypertensive medication 283 (39.0%) 140 (71.1%) 143 (27.1%) <0.001
eGFR (ml/min/1.73 m2) 89 ± 15 85 ± 16 90 ± 14 <0.001
Carotid-to-femoral pulse wave velocity (m/s) 8.9 ± 2.1 9.8 ± 2.4 8.5 ± 1.8 <0.001
Alcohol consumption
(no/low/high)
120/381/224
(16.6%/52.6%/30.9%)
53/103/41
(26.9%/52.3%/20.8%)
67/278/183
(12.7%/52.7%/34.7%)
<0.001
Smoking behaviour
(never/former/current)
226/384/115
(31.2%/53.0%/15.9%)
45/123/29
(22.8%/62.4%/14.7%)
181/261/86
(34.3%/49.4%/16.3%)
0.004
Prior cardiovascular disease 125 (17.2%) 56 (28.4%) 69 (13.1%) <0.001
Current depression 28 (3.9%) 11 (5.6%) 17 (3.2%) 0.142
Total (n ¼ 711) Type 2 diabetes (n ¼ 193) No type 2 diabetes (n ¼ 518) p-valuea
Carotid artery e distensibility coefﬁcient (103/kPa) 13.7 ± 4.8 12.2 ± 4.1 14.2 ± 4.9 <0.001
Carotid artery e compliance coefﬁcient (mm2/kPa) 0.65 ± 0.26 0.63 ± 0.24 0.66 ± 0.26 0.206
Carotid artery e Young's elastic modulus (103/kPa) 0.78 ± 0.36 0.86 ± 0.45 0.75 ± 0.31 <0.001
Carotid PP (mmHg)d 51 ± 14 56 ± 15 49 ± 13 <0.001
Data are presented as mean ± SD, median [IQR], or n (%).
BMI ¼ Body Mass Index; HDL ¼ high density lipoprotein; SBP ¼ systolic blood pressure; DBP ¼ diastolic blood pressure; MAP ¼mean arterial pressure; PP ¼ pulse pressure;
eGFR ¼ estimated glomerular ﬁltration rate.
a p-value for difference between individuals with and without type 2 diabetes, based on independent samples t-tests for continuous variables and Chi-square tests for
categorical variables.
b Obtained from blood pressure measurements every 5 min during vascular assessment.
c Hypertension was deﬁned as a systolic blood pressure 140 mmHg (based on ofﬁce blood pressure measurements [15]), a diastolic blood pressure  90 mmHg, and/or
current use of antihypertensive medication.
d N ¼ 708, of which n ¼ 191 with type 2 diabetes.
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normal and impaired glucose metabolism (data not shown). We
therefore did not analyse these groups separately.3.1. Arterial stiffness and cognitive performance
Table 2 shows the association between measures of arterial
stiffness and cognitive performance. After adjustment for age, sex,
and educational level, higher cfPWV tended to be associated with
impaired free recall memory (standardized regression coefﬁcient b
[95% CI] 0.063 [0.134 to 0.007], model 1) and information pro-
cessing speed (0.058 [0.129 to 0.013], model 1), but these as-
sociations did not reach statistical signiﬁcance. In the fully adjusted
models (model 3), cfPWV was not associated with cognitive
performance.
Lower carotid distensibility (CarDC) and compliance (CarCC)
were associated with worse information processing speed and
executive function and attention in fully adjusted models. Higher
Young's elastic modulus (CarYEM) was only statistically signiﬁ-
cantly associated with lower performance in executive function
and attention (b 0.081 [0.152 to 0.009], model 3). Indices of
carotid stiffness were not related to free recall memory (models
1e3). Calculations using the regression coefﬁcients of age and
indices of carotid stiffness (from the fully adjusted model, model 3)
showed that one standard deviation increase in carotid stiffness
was comparable with 1e2 years of ageing in the domain ofprocessing speed and 2e4 years of ageing in the domain of exec-
utive function and attention (data not shown).
The associations between measures of arterial stiffness and
cognitive functioning did not statistically signiﬁcantly differ be-
tween individuals with and without diabetes (p-values for
interaction 0.13).
3.2. Type 2 diabetes and cognitive performance
Table 3 shows the association between type 2 diabetes and
cognitive performance. After adjustment for age, sex, and educa-
tional level, the presence of type 2 diabetes was associated with
lower performance in all cognitive domains assessed (mean differ-
ence in cognitive domain scores for free recall memory [95%
CI]0.23 [0.37 to0.09]; processing speed0.16 [0.28 to0.04];
executive function and attention 0.26 [0.39 to 0.14]; model 1).
Additional adjustments for multiple cardiovascular risk factors and
current depression did not materially alter these associations (model
2). Raw cognitive test results for individuals with and without type 2
diabetes are presented in Table S2 (Online Supplement).
3.3. Type 2 diabetes and arterial stiffness
Table 4 shows the associations between type 2 diabetes and
measures of arterial stiffness. After adjustment for age and sex,
individuals with type 2 diabetes had higher cfPWV (mean
Table 2
Association between measures of arterial stiffness and cognitive performance.
Model Free recall Memory Processing speed Executive function & attention
Carotid-to-femoral pulse wave velocity
Model 1 0.063 (0.134 to 0.007) 0.058 (0.129 to 0.013) 0.008 (0.065 to 0.082)
Model 2 0.057 (0.136 to 0.021) 0.086a (0.166 to 0.007) 0.020 (0.062 to 0.102)
Model 3 0.028 (0.108 to 0.051) 0.067 (0.147 to 0.014) 0.047 (0.037 to 0.130)
Carotid artery e distensibility coefﬁcient
Model 1 0.032 (0.104 to 0.040) 0.060 (0.133 to 0.012) 0.125a (0.200 to 0.051)
Model 2 0.022 (0.101 to 0.057) 0.087a (0.166 to 0.008) 0.143a (0.224 to 0.061)
Model 3 0.007 (0.085 to 0.071) 0.083a (0.162 to 0.004) 0.133a (0.215 to 0.052)
Carotid artery e compliance coefﬁcient
Model 1 0.003 (0.065 to 0.071) 0.061 (0.130 to 0.007) 0.088a (0.159 to 0.018)
Model 2 0.012 (0.058 to 0.082) 0.073a (0.144 to 0.003) 0.091a (0.164 to 0.018)
Model 3 0.007 (0.063 to 0.076) 0.077a (0.147 to 0.007) 0.090a (0.163 to 0.018)
Carotid artery e Young's elastic modulus (103/kPa)
Model 1 0.011 (0.077 to 0.054) 0.046 (0.112 to 0.020) 0.088a (0.156 to 0.020)
Model 2 0.003 (0.072 to 0.065) 0.059 (0.128 to 0.010) 0.092a (0.163 to 0.021)
Model 3 0.008 (0.060 to 0.076) 0.054 (0.123 to 0.015) 0.081a (0.152 to 0.009)
Data are presented as standardized regression coefﬁcient (95% CI).
CI ¼ conﬁdence interval; SD ¼ standard deviation.
a p < 005. Regression coefﬁcients indicate the change in cognitive performance per SD increase in carotid-to-femoral pulse wave velocity or carotid Young's elastic modulus
and per SD decrease in carotid distensibility or compliance; in other words, a negative regression coefﬁcient means that greater arterial stiffness is associated with worse
cognitive performance. Model 1: adjusted for age, sex, and educational level; Model 2: additional adjustments for mean arterial pressure and heart rate (the latter only for
analyses of carotid-to-femoral pulse wave velocity); Model 3: additional adjustments for presence of type 2 diabetes, body mass index, total/high density lipoprotein-
cholesterol ratio, triglycerides, use of lipid-modifying medication, use of antihypertensive medication, estimated glomerular ﬁltration rate, smoking behaviour, alcohol
consumption, current depression, history of cardiovascular disease(s).
Table 3
Mean difference in cognitive domain scores between individuals with and without type 2 diabetes.
Model Free recall memory Processing speed Executive function & attention
Model 1 0.229a (0.371 to 0.088) 0.160a (0.278 to 0.042) 0.260a (0.385 to 0.136)
Model 2 0.230a (0.397 to 0.064) 0.187a (0.327 to 0.047) 0.231a (0.380 to 0.081)
Data are presented as unstandardized regression coefﬁcient (95% CI).
CI ¼ conﬁdence interval.
a p < 005. Individuals without diabetes were used as the reference group. Regression coefﬁcients indicate the mean difference in cognitive domain scores between in-
dividuals with and without type 2 diabetes. Model 1: adjusted for sex, age, and educational level; Model 2: additional adjustments for body mass index, total/high density
lipoprotein-cholesterol ratio, triglycerides, lipid-modifying medication, systolic blood pressure, diastolic blood pressure, antihypertensive medication, estimated glomerular
ﬁltration rate, smoking behaviour, alcohol consumption, current depression, and history of cardiovascular disease(s).
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lower, albeit not statistically signiﬁcant, CarDC (0.71 103/kPa
[1.44 to 0.02]) than individuals without diabetes (model 1). The
association between diabetes status and cfPWV weakened, but
remained signiﬁcant after further adjustment for haemodynamic
(0.49 m/s [0.21 to 0.77], model 2) and other cardiovascular risk
factors (0.45 m/s [0.12 to 0.78], model 3), whereas the trend with
CarDC was no longer observed in the fully adjusted model (0.31
103/kPa [1.15 to 0.48], model 3). The age- and sex-adjusted dif-
ferences in CarCC en CarYEM between individuals with and
without type 2 diabetes were not statistically signiﬁcant (model 1).Table 4
Mean difference in indices of arterial stiffness between individuals with and without typ
Model Carotid-to-femoral pulse wave
velocity (m/s)
Carotid artery e distensibility coefﬁcient
(103/kPa)
Model
1
0.618a (0.309e0.927) 0.710 (1.437 to 0.018)
Model
2
0.490a (0.207e0.773) 0.630 (1.294 to 0.035)
Model
3
0.450a (0.117e0.783) 0.309 (1.149 to 0.479)
Data are presented as unstandardized regression coefﬁcient (95% CI).
CI ¼ conﬁdence interval.
a p<005. Individuals without diabetes were used as the reference group. Regression c
dividuals with and without type 2 diabetes.Model 1: adjusted for sex and age;Model 2:
analyses of carotid-to-femoral pulse wave velocity);Model 3: additional adjustments for b
lipid-modifying medication, use of antihypertensive medication, smoking behaviour, est3.4. Mediation of the association between type 2 diabetes and
cognitive performance by arterial stiffness
Themediation analyses were restricted to the cognitive domains
observed to be associated with indices of carotid stiffness: infor-
mation processing speed and executive function and attention.
Differences in cognitive performance between individuals with and
without type 2 diabetes, adjusted for age, sex, and educational
level, were only slightly diminished after additional adjustment for
CarDC, CarCC, or CarYEM (maximum change in regression coefﬁ-
cient (i.e. change in mean differences in cognitive domain scores)e 2 diabetes.
Carotid artery e compliance coefﬁcient
(mm2/kPa)
Carotid artery e Young's elastic modulus
(103/kPa)
0.017 (0.059 to 0.024) 0.046 (0.013 to 0.106)
0.015 (0.055 to 0.026) 0.042 (0.015 to 0.099)
0.033 (0.080 to 0.015) 0.018 (0.049 to 0.086)
oefﬁcients indicate the mean difference in indices of arterial stiffness between in-
additional adjustments for mean arterial pressure and heart rate (the latter only for
odymass index, total/high density lipoprotein-cholesterol ratio, triglycerides, use of
imated glomerular ﬁltration rate, history of cardiovascular disease(s).
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In fully adjusted models there were no statistically signiﬁcant
mediation effects of carotid stiffness indices on the association of
type 2 diabetes with cognitive performance (data not shown).
Likewise, no mediation was found when exploring the combined
mediating effects of aortic and carotid stiffness (e.g. cfPWV and
CarDC, data not shown).
3.5. Sensitivity analyses
When carotid stiffness was calibrated with carotid instead of
brachial pulse pressure (PP), the results were largely similar to
those obtained with use of brachial PP (Tables S3 and S4, Online
Supplement), except for the association between type 2 diabetes
and carotid stiffness, which appeared slightly stronger (Table S3,
Online Supplement). Speciﬁcally, after adjustment for de-
mographics and haemodynamic factors, individuals with diabetes
had a statistically signiﬁcantly lower CarDC than those without
(mean difference [95% CI] 1.04 [1.94 to 0.15], model 1,
and 0.94 [1.71 to 0.16] 103/kPa, model 2, respectively), but
this association was not independent of other traditional cardio-
vascular risk factors (0.39 [1.31 to 0.53] 103/kPa, model 3).
Results of mediation analyses using indices of carotid stiffness that
were calibrated with carotid PP were similar to those obtained with
brachial PP (data not shown).
A more detailed analysis of the association between indices of
carotid stiffness and cognitive performance showed that only ca-
rotid distension was statistically signiﬁcantly associated with
cognitive performance, whereas carotid diameter and PP, as well
as brachial PP, were not (Table S5, Online Supplement). In addi-
tion, neither the augmentation index nor central PP appeared to
be associated with cognitive performance (Table S6, Online Sup-
plement). Mediation analyses performed in the fully adjusted
models showed that none of these individual variables had any
statistically signiﬁcant mediating effect on the association be-
tween type 2 diabetes and cognitive performance, nor when they
were combined with aortic stiffness (data not shown). Correlation
analyses revealed that indices of carotid stiffness were only
weakly to moderately correlated with cfPWV (Table S7, Online
Supplement).
Associations between type 2 diabetes and cognitive perfor-
mance, or between type 2 diabetes and arterial stiffness, may differ
between individuals with and without hypertension. However, we
found no such interaction, except for the association of diabetes
with impairments in executive function and attention, which was
present in individuals with hypertension (mean difference in
cognitive domain score [95% CI] 0.27 [0.45 to0.10]), but not in
individuals without hypertension (0.06 [0.39 to 0.27], fully
adjusted models). Additional mediation analyses performed in the
subgroup of individuals with hypertension showed that this as-
sociation also was not mediated by carotid stiffness (data not
shown).
Alternative adjustment for 24-h blood pressure and additional
adjustment for physical activity did not materially alter our results
(see Online Supplement).
4. Discussion
The results of this study show that greater carotid, but not aortic,
arterial stiffness is associated with worse cognitive performance,
both in individuals with and without type 2 diabetes. However,
indices of carotid stiffness do not mediate the relationship between
type 2 diabetes and worse cognitive performance.
Although interrelated, aortic and carotid stiffness are not
interchangeable [23]. Aortic stiffness, as reﬂected by cfPWV,involves a segment of the arterial tree with both elastic and
muscular properties [7], whereas the common carotid artery is a
predominantly elastic vessel. Muscular arteries are characterized
by a higher collagen to elastin ratio than elastic arteries [24].
Because the cushioning function progressively diminishes from the
most elastic to the more muscular arteries [7], pulsatile load on the
brain is particularly likely to increase with stiffening of elastic ar-
teries [25]. As such, differences in structural properties may explain
our ﬁnding that carotid, but not aortic, arterial stiffness was
negatively associated with cognitive performance. This is further
supported by our observation that stiffness of the femoral artery, an
artery of the muscular type, was not associated with cognitive
functioning (data not shown). Data from the ARIC (Atherosclerosis
Risk In Communities) study have previously indicated that carotid
stiffness is more strongly related to cerebrovascular disease (i.e.
incident ischemic stroke) [26], whereas femoral stiffness has been
suggested to be more strongly related to coronary heart disease
[25].
To our knowledge, only three other studies have investigated
the relationship between carotid stiffness and cognitive perfor-
mance, with conﬂicting results. In linewith our ﬁndings, ﬁndings of
two studies in middle-aged (n ¼ 58, mean age 53 ± 1 years) [9] and
late middle-aged (n ¼ 308, mean age 63 ± 6 years) [27] adults
showed that carotid stiffness was associated with decrements in
executive function and overall cognition [9,27], while cfPWV was
not consistently associated with cognitive performance in these
studies. In older individuals from the Rotterdam Study (n ¼ 3714,
mean age at baseline 72 ± 7 years), however, no association, neither
cross-sectionally nor longitudinally, was observed between CarDC
and (changes in) cognitive test scores after adjustment for cardio-
vascular risk factors [8]. Whether these differences in study results
can be explained by differences in age is at present unknown. Aortic
stiffness has been studied more frequently in relation to cognition.
Our ﬁnding that cfPWV was not related to cognitive performance
seems to be in contrast with most [4,8,9,28e41], but not all [42,43],
previous studies. Part of this discrepancy may be explained by the
fact that previous studies were often conduced in elderly subjects
(i.e. mean age over 70) [4,8,28e33,39] or individuals with (sub-
jective) memory loss [28e30,37], with larger between-individual
variation in cognitive performance, and frequently did not control
for potential confounders such as MAP [9,28e31,33,36,37] or
depressive symptoms [8,9,28e30,36,37,39]. Nonetheless, this does
not explain why our ﬁndings of cfPWV contrast with those of
comparable population-based cohort studies [34,38,40,41],
although this might be due to use of varying cognitive tests
focusing on different aspects of cognitive performance. Given the
current literature, we can thus not conclude from our data that
aortic stiffness is unrelated to cognitive performance, but our data
do suggest that carotid stiffness is more strongly associated with
impairments in cognitive performance.
Although further studies are needed to fully elucidate the
mechanisms that relate carotid stiffness to cognitive performance,
it can be speculated that an impaired cushioning function of elastic
arteries contributes to the development and progression of cerebral
small-vessel disease. The potential role of the arterial cushioning
function in linking carotid stiffness to cognitive performance is
illustrated by our observation that carotid distension, but not ca-
rotid diameter or PP, was associated with cognitive performance.
The consequential increase in pulsatile load on the brain is likely to
induce alterations in the cerebral microcirculation (e.g. hypertro-
phic remodelling and rarefaction of small arteries) which, in turn,
can lead to (chronic) cerebral ischaemia [44]. In this regard, our
ﬁnding that neither PP nor the augmentation index was associated
with cognitive performance may suggest that, as proposed previ-
ously [4], transmission of excessive ﬂow rather than pressure
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could, however, also reﬂect the fact that PP and the augmentation
index are indirect measures of arterial stiffness that depend on
multiple factors, including the duration and pattern of ventricular
contraction [7].
The idea that cerebral small-vessel disease may link carotid
stiffness to cognitive performance is supported by recent studies
showing that carotid stiffness is associated with higher volumes of
white matter hyperintensities [45,46] and non-lacunar infarcts
[46], independently of other vascular factors. Carotid stiffness does,
however, not predict the progression of cerebral small-vessel dis-
ease [46], which is inconsistent with small-vessel disease being an
important factor contributing to the observed decrements in
cognitive performance with carotid stiffness. Alternatively, carotid
stiffness may affect carotid baroreceptor sensitivity [47] or could
simply reﬂect structural changes in cerebral arteries including
increased collagen deposition, calciﬁcation, and ﬁbrosis.
It has been suggested that vascular factors [10], such as arterial
stiffness, may also be involved in the pathogenesis of diabetes-
associated cognitive problems. The proﬁle and magnitude of
diabetes-associated cognitive decrements in the present study are
comparable with those reported in systematic reviews [48] and
show that type 2 diabetes is associated with mild decrements in
multiple cognitive domains. In this context, the observed interac-
tion between diabetes and hypertension suggests that individuals
with both conditions are at especially high risk of cognitive
impairment, particularly in the domain of executive function and
attention. Our ﬁnding that type 2 diabetes was more strongly
associated with aortic than with carotid stiffness is consistent with
the concept that diabetes may affect the stiffness of muscular ar-
teries more strongly, or earlier, than of elastic arteries [12,49]. In
addition, the overall good glycaemic control of individuals with
diabetes in our cohort (HbA1c 6.9% [52 mmol/mol]) may have
attenuated the association between diabetes and carotid stiffness
in our cohort, because glycaemia and insulinaemia are major de-
terminants of (carotid) arterial stiffness in diabetes [12,50e52].
Obviously, the weak associations observed between type 2 diabetes
and carotid arterial stiffness made a mediation effect of carotid
arterial stiffness on the relationship between type 2 diabetes and
cognitive performance a priori unlikely. Therefore, we cannot
exclude that such mediation effects exist in diabetic individuals
with more severe carotid stiffening. In addition, our results do not
preclude the possibility that other vascular factors, such as (carotid)
atherosclerosis (i.e. large vessel pathology) or cerebral small vessel
disease (i.e. small vessel pathology), rather than or in addition to
metabolic variables, mediate the negative effects of type 2 diabetes
on cognitive performance.
Strengths of this study include the evaluation of both aortic and
local carotid arterial stiffness and the comprehensive set of de-
mographic, haemodynamic and cardiovascular variables that could
be taken into account in the analyses. Our study also had limita-
tions. First, we used a complete case analysis approach, which may
have resulted in underestimation of associations as individuals who
were excluded were generally slightly less healthy (Table S1, Online
Supplement). Notably, however, most of the missing data were
unavailable due to logical or technical reasons. Data imputationwas
considered, but as The Maastricht Study is an ongoing study that
aims to include 10,000 individuals, and the accuracy and validity of
imputation is likely to increase with increasing sample size and
increasing amount of data available, it was decided to wait until
data collection is completed before missing values will be imputed.
A second limitation is the fact that we were unable to capture all
aspects of cognitive functioning, which may also have led us to
underestimate the true association between arterial stiffness and
cognitive performance. Third, we did not adjust for multipletesting, thereby increasing the possibility of false positive ﬁndings.
We nonetheless believe that it is unlikely that the pattern we
observed, and that was consistent across multiple sensitivity ana-
lyses, is solely explained by the play of chance. A fourth limitation
concerns the accuracy of the calibration method used to determine
local carotid PP. Speciﬁcally, we cannot exclude the possibility of a
systematic error in our measurement of brachial MAP with
resulting errors in the absolute values of carotid PP. Note, however,
that such a systematic error would not affect the ranking of in-
dividuals, and hence is unlikely to have affected the outcome of the
sensitivity analyses in which local carotid PP was used. Last,
although we think that it is unlikely that (overall quite subtle)
cognitive impairment leads to stiffening of the arteries, the cross-
sectional nature of our study does not permit any conclusions on
causality.
In conclusion, the present study shows that carotid arterial
stiffness is associated with cognitive performance, but does not
mediate the relationship between type 2 diabetes and cognitive
dysfunction. Our ﬁndings indicate that stiffening of elastic and
muscular arteries may differentially affect brain function, high-
lighting the importance of markers of carotid stiffness in studies
linking arterial stiffening to brain function. Future (longitudinal)
studies are warranted to conﬁrm that our ﬁndings are not just a
chance ﬁnding and may shed light on the mechanisms involved.
Hypothetically, our results suggest that prevention and treatment
of increased carotid stiffness could serve as new targets to preserve
cognitive function, at least on a population level. The effectiveness
of interventions targeting carotid stiffness on the individual level
might be limited given the rather weak associations observed,
which, however, does not preclude carotid stiffening from being a
causative factor for cognitive deterioration and the development of
dementia.
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